Yudai Nishikawa

AR420626, a selective agonist of GPR41/FFA3, suppresses growth of hepatocellular carcinoma cells by inducing apoptosis <i>via</i> HDAC inhibition

Daisuke Mikami, Mamiko Kobayashi, Junsuke Uwada et al. · Therapeutic Advances in Medical Oncology · 2020 · 41 citations · Full text

Medicine, Oncology, Pharmacology +13

β-Hydroxybutyrate enhances the cytotoxic effect of cisplatin via the inhibition of HDAC/survivin axis in human hepatocellular carcinoma cells

Daisuke Mikami, Mamiko Kobayashi, Junsuke Uwada et al. · Journal of Pharmacological Sciences · 2019 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17

Tubulointerstitial Nephritis with IgM-Positive Plasma Cells

Naoki Takahashi, Takako Saeki, Atsushi Komatsuda et al. · Journal of the American Society of Nephrology · 2017 · 30 citations

Medicine, Nephrology, Pathology +16

Short-chain fatty acid mitigates adenine-induced chronic kidney disease via FFA2 and FFA3 pathways

Daisuke Mikami, Mamiko Kobayashi, Junsuke Uwada et al. · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · 2020 · 30 citations

Medicine, Nephrology, Pharmacology +16

β-Hydroxybutyrate, a ketone body, reduces the cytotoxic effect of cisplatin via activation of HDAC5 in human renal cortical epithelial cells

Daisuke Mikami, Mamiko Kobayashi, Junsuke Uwada et al. · Life Sciences · 2019 · 29 citations

Life Sciences, Molecular Biology, Pharmacology +14